FDA inspection
Eli Lilly and Company: FDA inspection ending Feb 11, 2026
FDA inspection 1309066 · Concord, NC
Key facts
| Inspection ID | 1309066 |
|---|---|
| Firm | Eli Lilly and Company |
| FEI number | 3027403675 |
| Address | 1420 Concord Pkwy S |
| City | Concord |
| State | NC |
| ZIP | 28027-9051 |
| Fiscal year | 2026 |
| Inspection end date | Feb 11, 2026 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data